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Protein-peptide interactions play a key role in cell functions. Their structural characterization, though 
challenging, is important for the discovery of new drugs. The CABS-dock web server provides an 
interface for modeling protein-peptide interactions using a highly efficient protocol for the flexible 
docking of peptides to proteins. While other docking algorithms require pre-defined localization of the 
binding site, CABS-dock doesn’t require such knowledge. Given a protein receptor structure and a 
peptide sequence (and starting from random conformations and positions of the peptide), CABS-dock 
performs simulation search for the binding site allowing for full flexibility of the peptide and small 
fluctuations of the receptor backbone. This protocol was extensively tested over the largest dataset of 
non-redundant protein-peptide interactions available to date (including bound and unbound docking 
cases). For over 80% of bound and unbound dataset cases, we obtained models with high or medium 
accuracy (sufficient for practical applications). Additionally, as optional features, CABS-dock can 
exclude user-selected binding modes from docking search or to increase the level of flexibility for 




Although protein-peptide interactions play key roles in cell functions, relatively little is known about 
the structural details of these complexes. The highly dynamic and transient nature of peptide binding 
makes experimental investigation difficult. Thus, computer aided support, like molecular docking, is 
needed. The major problem in molecular docking is the treatment of protein flexibility (1,2). Namely, 
current algorithms are not efficient enough to handle the high conformational fluctuations of peptides. 
An additional difficulty comes from the necessity of simultaneous dealing with the receptor’s flexibility, 
which, even if small, is extremely costly for most of the computational models.  
Computational protein-peptide docking is usually divided into three consecutive steps realized by 
separate protocols (3): (1) prediction of the binding site(s) on the receptor structure, (2) initial 
modeling of the peptide backbone in the binding site(s), and finally (3) refinement of the initial protein-
peptide complexes to high resolution. The CABS-dock method, presented in this paper, is an attempt 
to unify all these three steps into single, highly efficient simulation of coupled folding and binding of 
the peptide to the flexible receptor structure. To our knowledge, such an approach to docking, without 
prior knowledge of the binding site, has been successful so far only when applied to very short 
peptides (2 – 4 amino acids) (4). We tested performance of the CABS-dock protocol on a wide 
benchmark set of protein-peptide complexes with peptides of 5 – 15 amino acids. The benchmark 
contains 103 bound and 68 unbound protein receptor cases (determined experimentally in complex 
with a peptide and without a peptide, respectively).  
 
MATERIAL AND METHODS 
Previous applications and background 
The CABS-dock docking protocol was developed and validated during the following simulation 
studies: mechanism of folding and binding of an intrinsically disordered peptide (5); docking antigen-
mimicking peptides to an antibody (6); and docking peptide co-activators to nuclear receptors (7,8). 
These studies showed that the method is able to predict complex arrangements close to the native 
structure. Importantly, in all the validation tests mentioned above, peptides were allowed to be fully 
flexible and no information about the binding site or peptide conformation was used.  
The CABS-dock protocol is a multiscale modeling procedure based on the coarse-grained CABS 
protein model. The CABS model has been designed to provide significant efficiency in the treatment 
of protein conformational changes, while preserving high local accuracy (enabling seamless 
reconstruction to all-atom representation). In the CABS model, each amino acid is represented by up 
to four interaction centers, simulation dynamics is controlled by the Monte Carlo scheme, and the 
force field is based on statistical potentials (details have been described elsewhere (9)). Additionally 
to the aforementioned protein docking studies, we’ve demonstrated that the CABS protein model 
enables reliable simulations of protein dynamics: long-term folding mechanisms (10,11), and short-
term fluctuations close to the native state (12,13). CABS has also been successfully used in protein 
structure prediction exercises, showing exceptional performance especially in blind predictions of 
short globular proteins (14) and large protein fragments (15,16). Altogether, these studies 
demonstrate the validity of the CABS interaction model and sampling scheme in simulations of 
simultaneous folding and binding, such as performed in the CABS-dock protocol.  
Protocol overview 
The CABS-dock protocol consists of the following steps (presented also in Figure 1 and Figure S1 
flow-chart):  
(1) Generating random structures. Random structures of the peptide are generated and randomly 
placed on the surface of the sphere centered at the receptor’s geometrical center (the radius of the 
sphere is the receptor dimension in the longest direction + 20 angstroms). 
(2) Simulation of binding and docking. The CABS-dock procedure utilizes Replica Exchange Monte 
Carlo dynamics with 10 replicas uniformly spread on the temperature scale. Additionally the 
temperatures of the replicas constantly decrease as the simulation proceeds to end on the bottom of 
the energy minima. On output the procedure produces 10 trajectories (one for each replica), each 
consisting of 1000 time-stamped simulation snapshots for a combined total of 10000 models. During 
the simulation, the receptor molecule is kept in near-native conformations by a set of distance 
restraints binding pairs of C-alpha atoms. The restraints are selected from the distance map 
calculated on the input structure based on the following conditions: only C-alpha atoms located within 
a 5-15 Å range from each other are restrained; the minimum sequence gap between restrained 
residues is set to 5; violation of the restraint by less than 1 Å is not penalized; beyond that the 
energetic penalty increases linearly. If the user marks some of the residues as semi-flexible or fully 
flexible, the slope of the penalty is halved or set to 0, respectively, for all restraints assigned to the 
marked residues. 
(3) Selection of the final models is a two-step procedure: 
 Initial filtering. From each of the 10 trajectories, all unbound states are excluded and next 100 
lowest binding energy models are selected (or less if a trajectory contains less than 100 
bound states, which is rarely the case), for the next step of the procedure. 
 K-medoids clustering. Selected models (1000 in total) are clustered together in the k-medoids 
procedure. Clustering is performed 100 times with different initial medoids and k=10. Ten 
consensus medoids are selected as the final models. 
(4) Reconstruction of the final models. Final models are reconstructed from the C-alpha trace to an 
all-atom representation and subsequently undergo optimization using Modeller (17) with DOPE 
statistical potential (18). 
 
PERFORMANCE 
Docking without prior knowledge of the binding site 
We have validated the CABS-dock docking protocol against the largest dataset of non-
redundant peptide–protein interactions (<70% sequence identity with respect to the receptor protein) 
available to date. The benchmark was originally created to test the FlexPepDock refinement 
procedure (3), and subsequently extended (with new unbound cases) in a study testing the 
HADDOCK algorithm (docking driven by knowledge of the binding site) (19). 
We assess the quality of docking models using ligand RMSD (root mean square deviation) as 
follows: 
 High-quality prediction: RMSD < 3 Å 
 Medium-quality prediction: 3 Å ≤ RMSD ≤ 5.5 Å 
 Low-quality prediction: RMSD > 5.5 Å 
The RMSD is calculated on the peptide only, after superimposition of the receptor structures. 
We’ve decided to set up an arbitrary cut-off of 5.5 Å (between low and medium accuracy models) on 
the basis of the work benchmarking the Rosetta FlexPepDock protocol for the refinement of coarse 
models of protein-peptide complexes (3). In that work, the authors defined an effective “basin of 
attraction” of 5.5 Å resolution, from which the FlexPepDock protocol is able to reliably recover near-
native protein-peptide models (in 91% of bound docking cases). Importantly, low-quality prediction (as 
defined by the 5.5 Å cut-off) doesn’t mean that the obtained models are useless for further refinement. 
In the FlexPepDock benchmark, starting the refinement from structures of 6.5–7.5 Å resolution 
resulted in near-native models in 48% of cases of bound docking (3). 
In our performance test, we used neither information about the bound peptide structure nor about 
the binding site (blind prediction test). As shown in Figure 2, within the set of resulting models, high or 
medium accuracy models can be found, both in the entire set of predicted models (all) or in the top 
selected models (top 10) (for the detailed results of bound and unbound cases see Table S1 and 
Table S2, respectively). Moreover, the CABS-dock performance for bound cases is on the same level 
as that for unbound cases (the pairs of bound and unbound counterparts are listed in Table S3). This 
is because, for the majority of benchmark cases, the difference between binding interfaces of bound 
and unbound protein forms is small (lower than 1 Å (19)). Therefore, such small protein changes are 
well handled by CABS-dock using the default settings of protein receptor flexibility.  
In summary, for over 80% of bound and unbound dataset cases, we obtained models with high or 
medium accuracy that is sufficient for practical applications (at least for further refinement to higher 
resolution (3)). The prediction results may qualitatively differ between different prediction runs (due to 
stochastic nature of the simulation model). The analysis of the accuracy of the predicted models in 
different prediction runs showed that the modeling cases generally fall into two categories: those with 
consistent and those with qualitatively distinct predictions (see Table S1 and Table S2). Therefore in 




Input interface and requirements 
The required input includes: 
 Protein receptor structure in the PDB format or protein PDB code along with the chain 
identifier(s), for example: 1RJK:A or 1CE1:HL. The following requirements apply to the input 
PDB files: single or multi-chain proteins are accepted (chains must be up to 500 amino acids 
in length); each residue in the provided PDB file should have a complete set of backbone 
atoms (i.e.: N, Cα, C and O); side chain atoms may be missing. Non-standard amino acids 
are automatically changed to their standard counterparts. 
 Peptide sequence (in one letter code, standard amino acids only, maximum 30 amino acids in 
length) 
The optional input includes: 
 Peptide secondary structure. If not provided, the PSI-PRED method (20) for secondary 
structure prediction is automatically used. For best results, if the peptide secondary structure 
was derived experimentally, we suggest providing experimental assignments. The secondary 
structure should be provided for each residue in a three letter code: H, helix; E, extended 
state (beta strand); and C, coil (less regular structures). Overpredictions of the regular 
secondary structure (H or E) are more dangerous for the quality of the results than 
underpredictions (i.e. for residues with an ambiguous secondary structure prediction 
assignment, it is better to assign coil (C) than a regular (H or E) structure).  
 Project name. Recommended for better organization of users’ work: project names appear in 
the queue page.  
 Email address. If provided, the server will send an email notification about job completion. 
 Advanced options (described in a separate paragraph below). 
 
Output interface 
The output interface is organized under the following tabs: 'Project information', ‘Docking 
prediction results’, 'Clustering details' and ‘Contact maps’. The content of the latter three is briefly 
described in the following paragraphs. 
Under the “Docking prediction results” tab (see the screenshot in Figure 3 A) the user may view in 
3D and download 10 final models (representatives of 10 structural clusters found in the simulation – 
for details see Protocol overview in Methods). Additionally, the user may download a compressed 
archive with 10 final models, cluster models (all models that have been classified in structural 
clustering to particular clusters) and complete trajectories (in the PDB format and C-alpha 
representation). The archive also contains the input structure of the receptor and a log file with all 
information to recreate the simulation. 
 Under the “Clustering details” tab (see the screenshot in Figure 3 B) the user is provided with 
thorough insight into structural clustering data. An interactive chart shows the composition of clusters 
of models vs. their trajectory affiliation. By clicking on the points representing models in the chart, the 
user may view in 3D and download particular models in the PDB format. The tab also contains a table 
summarizing basic information on clusters, such as density, diversity, etc. 
The “Contact maps” tab allows the user to investigate the interaction interface between the peptide 
and the receptor. An interactive chart shows a contact map between the peptide and the receptor 
residues. The user may define the value of the contact cutoff distance. The user also has a text list of 
the contacts shown on the maps.  
Advanced options 
For more advanced prediction runs, users may perform the following operations: 
 Excluding binding modes. The user may select receptor residues that are unlikely to 
interact with the peptide to exclude some binding modes from the results. The user may 
provide such a list explicitly (available from the main page by checking the “Mark unlikely 
to bind regions” option) or resubmit an already completed job (available in ‘Project 
information’ tab) with marked models (binding modes) to be excluded from future results. 
 Allowing for the higher flexibility of selected receptor fragments. This advanced option 
enables removing distance restraints that keep the receptor structure in a near native 
conformation (see Protocol overview in Methods section). For each selected residue, the 
user may choose from two preset settings: moderate or full flexibility. This option is 
available from the main page by checking the “Mark flexible regions” option. 
 Increasing simulation length. The user may increase the default (50) number of Monte 
Carlo macrocycles to be performed (the maximum number is 200). Increasing this number 
may be beneficial in more difficult modeling cases (e.g. for large receptor structures or for 
long peptides of more than 20 residues). However, an alternative way for dealing with 
such more demanding cases is to run independent simulation runs, and to analyze the 
results jointly.  
Online documentation 
CABS-dock documentation is available online and can be accessed using the links in the menu at 
the top of every server page. It contains a description of the method and a tutorial explaining how to 
access and interpret resulting data. The online documentation is updated on a regular basis according 
to users’ needs or method improvements. 
Server and output data availability 
The CABS-dock server is free and open to all users, and there is no login requirement. After 
clicking on the submit button, a web link to the results is provided which can be bookmarked and 
accessed at a later time. Web links to the submitted jobs are also displayed on a queue page 
(available from the main page), unless the option ‘Do not show my job on the results page’ (available 
from the options panel in the main page) is marked. Note that the results will be available for a limited 
period of time (notification about data storage is displayed at the bottom of the job page). 
Server architecture and run-time 
The CABS-dock website interface and parsers were developed in the Python scripting language, 
using Flask framework and Jinja2 template engine. The molecular visualization used in the server is 
executed using 3Dmol.js (21) and JSmol (22). The CABS-dock website runs on the Apache2 and 
SQLite3 database for user queue storage. The CABS-dock queue is checked every 5 minutes by 
computational servers and any new jobs are added to the SGE queue. As soon as a job is started on 
the computational server, job status changes on the CABS-dock website (from 'pending' to 'running').  
A Typical CABS-dock run takes about 3 hours. After completion, job results are sent back to the 
website and job status changes from 'running' to 'done' (or 'error'). Currently, CABS-dock server 
computations are performed on a Linux supercomputer cluster having about 100 CPU threads. 
 
SUMMARY 
The CABS-dock protocol has been already successfully used in studies of protein-peptide interactions 
(5-8). Within this work, we developed an easy-to-use web server interface for the CABS-dock protein-
peptide docking protocol. We expect that this web server will be widely applied to new systems as 
well as utilized as an element of new modeling procedures. The promising CABS-dock extensions 
include for example: adding a refinement step (19,23), incorporation of experimental data, increasing 
the flexibility of appropriate receptor fragments (e.g. through predicted restraints (24)). 
 
SUPPLEMENTARY DATA 
Supplementary Data are available at NAR Online: Figure S1, Table S1, Table S2, Table S3. 
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TABLE AND FIGURES LEGENDS 
 
 
Figure 1. Basic stages of the CABS-dock protocol illustrated on the example benchmark case (PDB 
ID: 2P1T). The protein receptor is colored in green, modeled peptide conformations in magenta and 
the reference experimental peptide structure in yellow. The following CABS-dock stages are 
visualized: (1) simulation start (from random conformations and positions of the peptide); (2) 
simulation result (a set of 10,000 models); (3) filtering and clustering result (a set of models grouped 
in similar binding modes and similar peptide conformations); (4) final models (a set of 10 
representative models). In the presented benchmark case, 7 of the 10 final models were docked in 
the native binding site (marked in red rectangle). Among these, the best accuracy model was within 
1.37 Å to the native (shown in the right bottom corner superimposed on the native peptide structure). 
For a more detailed flow-chart of the CABS-dock pipeline, see Figure S1. 
 Figure 2. CABS-dock performance summary for 103 bound and 68 unbound benchmark cases. The 
percentages of high, medium or low accuracy models (quality assessment criteria are given in the text) 
are reported over all generated models (all: 10,000 models) and top 10 selected models. Detailed 
results, for each modeled complex and each prediction run, are available in Table S1 (bound docking 
cases) and Table S2 (unbound docking cases). 
 Figure 3. CABS-dock web server screenshots. Example output interface is presented: (A) ‘Docking 
prediction results’ tab, and (B) 'Clustering details' tab. 
Supplementary data 
Figure S1. Flow-chart of the CABS-dock protocol. 
 
Table S1. CABS-dock performance for 103 bound cases (listed in rows) in 3 independent prediction runs (shown in separate columns). The table 
shows the lowest ligand-RMSD values (calculated on the peptide only after superimposition of the receptor structures) among: all 10,000 models 
(all), top 1000 models (top 1k, selected during filtering and clustering procedure), top 100 models (top 100, selected through further clustering) and 
top 10 final models (top 10). Last column shows the lowest RMSD values obtained in three prediction runs. 
receptor receptor  peptide Run 1 Run 2 Run 3  best from all runs 
pdb id length (AA) length (AA) all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 
1awr 164 6 1.51 2.48 2.92 2.83 1.99 1.99 2.82 5.52 1.86 1.89 2.83 3.97 1.51 1.89 2.82 2.83 
1ce1 431 8 1.73 2.14 3.34 4.23 2.76 3.31 3.76 5.45 3.12 3.48 4.32 3.86 1.73 2.14 3.34 3.86 
1cka 57 9 3.45 3.54 4.73 5.03 3.4 3.73 4.36 5.08 3.09 3.37 4.03 4.45 3.09 3.37 4.03 4.45 
1czy 168 7 2.68 4.51 11.58 18.99 1.91 2.21 2.4 3.05 2.39 3.37 6.06 11.05 1.91 2.21 2.4 3.05 
1d4t 104 11 4.8 5.61 7.37 8.17 1.97 1.97 2.2 2.63 2.15 2.97 3.18 3.85 1.97 1.97 2.2 2.63 
1ddv 104 6 2.52 2.94 3.97 3.82 3.24 3.88 4.75 4.07 3.08 3.53 4.7 6.92 2.52 2.94 3.97 3.82 
1dkx 219 7 8.49 8.49 9.11 8.84 7.93 7.93 8.19 9.4 9.59 9.74 10.29 12.78 7.93 7.93 8.19 8.84 
1eg4 260 13 6.73 8.61 8.97 11.08 9.57 11.38 12.26 16.18 6.57 13.12 13.39 13.7 6.57 8.61 8.97 11.08 
1elw 117 8 1.96 1.96 2.53 3.8 2.18 2.94 3.3 4.87 2.56 2.56 3.38 4.57 1.96 1.96 2.53 3.8 
1er8 330 8 6.33 6.92 6.92 6.92 7.11 7.11 7.78 8.68 6.39 6.39 6.9 8.9 6.33 6.39 6.9 6.92 
1gyb 122 5 4.53 8.62 11.55 16.66 4.79 7.5 14.76 15.15 4.98 7.67 10.99 14.83 4.53 7.5 10.99 14.83 
1h6w 151 10 6.1 18.63 19.07 25.35 8.22 8.22 19.27 20.32 9.46 10.2 12.11 25.23 6.1 8.22 12.11 20.32 
1hc9 74 13 6.87 10.59 12.91 14.26 6.21 6.52 7.17 7.94 6.67 11.81 13.69 14.5 6.21 6.52 7.17 7.94 
1i8k 225 10 3.6 4 4.04 8.5 5.53 5.82 7.2 7.64 4.92 5.5 6.94 7.8 3.6 4 4.04 7.64 
1iak 367 13 3.4 4.19 4.19 5.13 5.56 8.19 10.16 18.04 3.98 3.98 5.2 5.85 3.4 3.98 4.19 5.13 
1ihj 94 5 2.58 3.71 4.42 6.99 2.7 2.72 5.29 6.5 2.17 4.84 5.67 7.03 2.17 2.72 4.42 6.5 
1jbu 239 15 7.73 9.67 13.45 19.68 9.39 14.52 14.52 26.58 7.39 13.46 21.87 24.87 7.39 9.67 13.45 19.68 
1jd5 105 8 2.85 2.85 5.88 16.12 5.31 13.06 15.47 20.07 6.04 9 11.69 15.18 2.85 2.85 5.88 15.18 
1jwg 140 5 2.53 3.48 4.41 5.27 2.29 2.29 3.92 6.75 2.38 2.38 4.21 5.87 2.29 2.29 3.92 5.27 
1kl3 120 6 2.6 3.51 5.14 5.33 2.91 4.33 4.82 5.92 2.45 4.29 4.92 5.21 2.45 3.51 4.82 5.21 
1klu 369 15 3.57 3.89 4.79 5.86 3.64 3.91 4.5 5.3 3.75 3.8 5.02 6.27 3.57 3.8 4.5 5.3 
1lvm 229 7 6.13 7.88 17.09 13.47 5.68 9.59 12.52 14.37 5.42 6.07 14.41 15.07 5.42 6.07 12.52 13.47 
1mfg 95 9 4.62 4.86 6.78 9.49 2.99 4.6 10.1 7.37 3.71 3.71 7.25 6.78 2.99 3.71 6.78 6.78 
1mvu 333 13 4.26 4.26 5.47 9.85 3.74 4.33 4.89 5.29 3.29 4.84 6.58 7.77 3.29 4.26 4.89 5.29 
1n12 136 11 8.43 8.43 9.4 12.11 8.31 8.31 8.72 10.46 9.46 9.89 12.78 14.93 8.31 8.31 8.72 10.46 
1n7f 86 8 4.18 7.13 7.81 9.15 4.22 7.07 12.76 12.42 4.72 6.2 10.91 13.1 4.18 6.2 7.81 9.15 
1nln 203 11 3.34 3.62 3.97 5.23 5.57 7.07 8.61 12.81 3.07 3.7 3.74 12.51 3.07 3.62 3.74 5.23 
1nq7 244 10 2.85 2.85 2.85 8.31 1.03 1.03 1.11 4.66 1.17 1.17 2.47 2.73 1.03 1.03 1.11 2.73 
1ntv 152 10 3.14 3.14 5.92 10 2.89 2.89 3.71 5.28 3.6 4.3 5.39 14.3 2.89 2.89 3.71 5.28 
1nvr 264 5 5.24 6.2 9.11 8.68 2.83 2.83 6.39 7.5 1.68 1.68 4.06 4.15 1.68 1.68 4.06 4.15 
1nx1 173 11 3.03 3.2 3.7 4.2 2.82 2.98 3.26 4.68 2.92 2.94 3.33 4.95 2.82 2.94 3.26 4.2 
receptor receptor  peptide Run 1 Run 2 Run 3  best from all runs 
pdb id length (AA) length (AA) all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 
1oai 59 9 3.81 4.86 5.27 6.84 3.04 3.56 5.54 6.68 3.23 4.75 6.18 6.53 3.04 3.56 5.27 6.53 
1ou8 106 8 4.17 4.17 5.93 9.04 4.86 7.38 9.21 10.79 2.98 3.97 5.65 5.56 2.98 3.97 5.65 5.56 
1pz5 435 8 4.58 4.58 5.8 5.63 4.69 5.18 5.32 5.22 5.02 5.97 7.73 8.22 4.58 4.58 5.32 5.22 
1qkz 219 10 5 6.45 10.31 15.24 6.71 7.72 11.97 13.27 6.96 6.96 6.96 10.69 5 6.45 6.96 10.69 
1rxz 245 11 6.76 6.76 11.68 13.38 4.46 5.22 8.5 11.28 3.54 3.9 6.16 6.11 3.54 3.9 6.16 6.11 
1se0 97 7 6.16 7.78 11.06 17.95 4.05 4.05 9.08 7.55 5.34 7.02 9 9.06 4.05 4.05 9 7.55 
1sfi 223 14 7.8 7.8 10.63 13.04 7.18 7.18 7.36 7.77 6.74 8.53 8.78 11.51 6.74 7.18 7.36 7.77 
1ssh 60 11 3 4.79 5.35 7.05 4.19 4.67 5.44 5.41 3.74 4.32 5.33 5.68 3 4.32 5.33 5.41 
1svz 232 6 2.98 2.98 3.82 6.82 2.17 2.17 3.77 5.13 2.8 4.43 5.05 5.19 2.17 2.17 3.77 5.13 
1t4f 88 9 2.59 3.1 3.82 4.58 2.81 2.88 2.93 3.02 2.78 2.79 3.43 4.23 2.59 2.79 2.93 3.02 
1t7r 250 10 1.94 2.15 2.52 3.35 1.61 2.05 2.05 2.13 1.73 1.92 2.92 1.88 1.61 1.92 2.05 1.88 
1tp5 115 6 4.28 7.19 9.28 8.47 1.68 1.73 2.64 3.57 1.15 1.45 2.46 3.76 1.15 1.45 2.46 3.57 
1tw6 95 6 3.31 3.93 10.22 8.47 3.27 5.75 10.99 17.83 4.33 7.61 11.44 7.22 3.27 3.93 10.22 7.22 
1u00 227 9 8.89 8.89 10.59 11.43 9.67 10.85 11.07 11.86 8.95 9.28 9.28 11.21 8.89 8.89 9.28 11.21 
1u8i 441 7 5.85 13.62 19.63 19.99 6.5 9.66 13.42 13.84 5.75 9.79 10.1 16.59 5.75 9.66 10.1 13.84 
1u9l 138 7 10.81 10.81 11.61 12.46 8.77 8.77 8.96 9.25 10.06 10.06 10.76 10.64 8.77 8.77 8.96 9.25 
1uj0 58 9 3.44 3.53 4.29 5.19 3.49 3.49 4.57 4.83 4.1 4.71 4.9 5.37 3.44 3.49 4.29 4.83 
1vzq 250 6 2.98 4.02 6.61 10.51 2.76 4.5 5.03 6.71 3.73 5.85 6.35 7.21 2.76 4.02 5.03 6.71 
1w9e 164 5 3.77 6.17 11.09 17.41 5.4 5.76 9.04 16.41 4.19 13.05 16.34 17.86 3.77 5.76 9.04 16.41 
1x2r 290 9 4.95 5.02 5.04 5.1 2.89 4.85 6.54 7.13 3.89 5 5.78 7.1 2.89 4.85 5.04 5.1 
1xoc 504 9 19.49 19.49 20.94 21.66 17.64 17.97 18.06 20.33 18.15 18.15 18.15 19.29 17.64 17.97 18.06 19.29 
1ymt 235 10 2.98 2.99 4.12 5.98 2.54 2.77 2.89 3.28 2.79 3.53 3.72 4.54 2.54 2.77 2.89 3.28 
1yph 228 10 4.23 5.19 5.19 7.27 4.03 4.03 4.66 4.63 3.27 12.4 13.23 13.44 3.27 4.03 4.66 4.63 
1yuc 240 14 3.29 5.35 6.96 7.92 2.89 3.68 5.25 6.13 4.83 8.22 12.26 13 2.89 3.68 5.25 6.13 
1ywo 55 10 2.97 5.09 5.98 7.62 3.95 4.25 6.8 8.07 4.21 4.6 6.01 6.46 2.97 4.25 5.98 6.46 
1z9o 238 9 4.61 6.68 7.19 8.37 5.18 6.44 6.83 8.28 5.12 6.03 7.31 8.63 4.61 6.03 6.83 8.28 
1zuk 130 11 2.93 3.48 4.53 5.19 3.18 3.18 4.58 4.43 3.2 3.38 3.64 4.46 2.93 3.18 3.64 4.43 
2a3i 253 12 3.59 4.14 5.31 5.25 1.7 2.56 3.54 4.02 1.68 2.1 2.1 5.49 1.68 2.1 2.1 4.02 
2ai4 111 8 5.94 8.48 8.51 9.49 9.6 11.5 14.81 15.92 7.93 11 13.87 14.01 5.94 8.48 8.51 9.49 
2ak5 64 8 3.59 3.6 4.79 6.69 4.29 4.29 6.56 6.57 3.57 3.57 5.23 5.38 3.57 3.57 4.79 5.38 
2b1z 238 9 0.91 1.15 1.31 1.5 2.28 2.51 2.52 3.46 0.82 1.05 1.18 1.16 0.82 1.05 1.18 1.16 
2b9h 337 12 5.19 9.46 9.7 10.71 2.57 2.9 3.11 2.96 4.53 4.53 14 21.87 2.57 2.9 3.11 2.96 
2bba 185 14 4.08 4.79 6.87 7.1 3.53 3.65 5.17 5.26 3.91 4.58 5.41 5.57 3.53 3.65 5.17 5.26 
2c3i 266 8 6.09 7.29 8.93 11.16 5.12 6.69 8.61 11.37 3.16 6.05 9.94 11.43 3.16 6.05 8.61 11.16 
2cch 256 12 6.04 7.77 10.11 12.51 4.38 5.26 11.49 11.47 3.36 7.15 11.11 26.01 3.36 5.26 10.11 11.47 
receptor receptor  peptide Run 1 Run 2 Run 3  best from all runs 
pdb id length (AA) length (AA) all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 
2d0n 56 9 3.41 3.66 4.42 6.02 3.27 3.67 4.23 4.68 2.64 2.64 4.22 5.64 2.64 2.64 4.22 4.68 
2d5w 602 5 18.64 19.17 19.48 21.23 17.99 18.59 20.08 20.39 18.52 18.52 19.65 20.13 17.99 18.52 19.48 20.13 
2ds8 41 6 4.97 4.97 10.05 9.46 3.25 3.25 8.87 9.77 2.15 2.15 5.45 9.42 2.15 2.15 5.45 9.42 
2dze 320 6 2.39 2.71 2.71 3.13 2.82 2.97 3.23 3.59 7.08 7.45 7.8 8.58 2.39 2.71 2.71 3.13 
2fgr 332 8 6.29 13.42 14.19 15.87 9.8 13.72 14.8 16.07 4.96 13.75 13.75 16.49 4.96 13.42 13.75 15.87 
2fmf 128 13 2.87 2.87 7.07 7.5 4.46 4.64 6.09 7.18 4.77 5.14 5.92 6.43 2.87 2.87 5.92 6.43 
2fnt 198 7 0.76 0.8 0.8 1.12 4.94 4.94 4.98 5.68 8.72 8.72 8.72 10.73 0.76 0.8 0.8 1.12 
2foj 137 7 3.29 3.73 3.94 5.97 2.65 2.92 4.34 4.4 5.38 5.38 8.06 13.62 2.65 2.92 3.94 4.4 
2fvj 258 10 1.62 1.82 1.82 2.43 1.46 1.46 1.46 3.49 1.73 2.86 3.31 3.66 1.46 1.46 1.46 2.43 
2h9m 304 5 1.79 1.8 1.8 4.42 3.1 3.1 3.43 4.96 1.36 3 3.22 4.86 1.36 1.8 1.8 4.42 
2ho2 33 10 4.32 6.62 8.82 15.21 3.94 4.89 6.48 7.04 3.8 5.63 6.33 5.59 3.8 4.89 6.33 5.59 
2hpl 100 5 1.28 2.66 3.45 3.94 1.99 2.34 4.06 5.22 1.76 2.08 4 5.16 1.28 2.08 3.45 3.94 
2ipu 442 7 5.04 5.5 6.47 8.75 7.4 7.57 9.74 17.13 5.42 7.49 11.56 10.82 5.04 5.5 6.47 8.75 
2iv9 469 9 5.84 7.49 8.44 8.45 3.91 4.1 7.82 8.3 3.06 4.9 6.59 6.73 3.06 4.1 6.59 6.73 
2j6f 57 8 2.96 5.25 11.17 11.37 3.33 3.49 3.95 5.29 2.98 3.73 4.42 5.37 2.96 3.49 3.95 5.29 
2jam 279 6 4.98 7.86 12.7 15.99 4.34 7.51 11.81 17.2 6.16 8.41 12.8 13.62 4.34 7.51 11.81 13.62 
2o02 224 14 3.99 5.54 6.41 6.68 3.97 4.08 4.86 4.92 3.54 3.71 4 5.19 3.54 3.71 4 4.92 
2o4j 240 12 1.49 2.26 2.41 2.81 1.54 2.02 2.69 2.95 6.07 7.81 11.78 12.76 1.49 2.02 2.41 2.81 
2o9v 67 10 3.64 3.85 5.4 6.6 3.76 4.35 5.36 9.44 3.38 3.73 4.6 5.39 3.38 3.73 4.6 5.39 
2otu 233 11 4.33 4.33 16.41 15.01 3.15 4.24 6.09 8.79 4.57 7.24 16.38 21.54 3.15 4.24 6.09 8.79 
2p0w 319 15 5.88 7.98 7.98 14.35 6.05 14.01 14.57 15.25 6.26 6.26 6.38 15.07 5.88 6.26 6.38 14.35 
2p1k 87 11 3.52 4.76 5.27 5.38 6.33 9.82 10 10.33 2.47 2.47 3.06 4.08 2.47 2.47 3.06 4.08 
2p1t 211 10 0.97 1.34 1.35 1.37 1.38 1.61 2.15 2.79 0.9 0.9 1.3 1.44 0.9 0.9 1.3 1.37 
2p54 267 12 3.35 3.35 3.54 3.96 3.07 3.07 3.61 3.85 1.66 2.25 2.61 2.02 1.66 2.25 2.61 2.02 
2puy 60 10 6.13 7.84 18.61 21.21 6.3 6.3 10.36 10.35 3.63 3.63 8.7 12.44 3.63 3.63 8.7 10.35 
2pv2 206 12 2.27 2.27 3.6 3.77 3.26 3.81 4.73 5.82 1.72 1.72 1.72 4.43 1.72 1.72 1.72 3.77 
2qos 173 11 3.11 4.16 6.57 6.88 3.53 4.83 5.87 6.79 3.17 3.94 4.65 5.76 3.11 3.94 4.65 5.76 
2r7g 337 10 1.47 1.62 1.62 3.33 2.34 2.85 3.53 4.97 2.94 3.7 4.03 5.09 1.47 1.62 1.62 3.33 
2v3s 96 6 2.42 2.42 3.48 8.89 1.83 1.83 5.01 7.24 1.05 1.09 1.74 2 1.05 1.09 1.74 2 
2vj0 246 8 2.09 2.96 4.12 3.91 3.83 8 21.4 21.43 3.57 5.07 6.5 7.75 2.09 2.96 4.12 3.91 
2zjd 121 10 2.35 2.69 2.79 4.6 1.77 1.83 1.91 3.78 1.57 1.58 2.27 3.7 1.57 1.58 1.91 3.7 
3bfq 132 15 10.2 11.53 14.22 13.48 1.24 1.41 1.83 2.58 11.81 18.52 21.98 23.03 1.24 1.41 1.83 2.58 
3bu3 297 14 6.87 7.06 7.71 8.86 5.77 5.77 10.23 11.07 6.12 10.01 10.01 10.42 5.77 5.77 7.71 8.86 
3bwa 276 8 2.42 2.75 3.17 3.94 2.39 2.51 2.98 3.2 1.83 2.7 3.19 3.65 1.83 2.51 2.98 3.2 
3cvp 279 6 4.52 4.67 8.47 10.14 3.07 4.97 5.68 7.59 3.08 4.25 5.49 8.02 3.07 4.25 5.49 7.59 
receptor receptor  peptide Run 1 Run 2 Run 3  best from all runs 
pdb id length (AA) length (AA) all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 
3d1e 366 6 4.39 6.59 8.18 18.82 3.44 3.44 9.96 8.93 2.57 2.57 9.88 12.21 2.57 2.57 8.18 8.93 
3d9t 95 6 3.56 4.34 7.25 10.06 3.12 4.28 7.25 9.16 3.02 3.91 11.05 15.91 3.02 3.91 7.25 9.16 
MEAN 204.81 9.17 4.41 5.53 7.32 9.11 4.38 5.32 7.13 8.52 4.38 5.71 7.49 9.26 3.61 4.32 5.62 6.90 
 
 Table S2. CABS-dock performance for 68 unbound cases (listed in rows) in 3 independent prediction runs (shown in separate columns). The table 
shows the lowest ligand-RMSD values (calculated on the peptide only after superimposition of the receptor structures) among: all 10,000 models 
(all), top 1000 models (top 1k, selected during filtering and clustering procedure), top 100 models (top 100, selected through further clustering) and 
top 10 final models (top 10). Last column shows the lowest RMSD values obtained in three prediction runs. 
pdb  receptor  peptide run 1 run 2 run 3  best from 3 runs 
code length (AA) length (AA) all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 
1alv 173 11 1.99 2.55 3.6 3.32 2.83 3.24 3.73 4.87 1.68 2.12 3.2 2.47 1.68 2.12 3.2 2.47 
1b9k 246 8 3.38 6.89 9.74 9.95 4.07 10.06 14.05 22.2 4.74 6.18 10.07 10.59 3.38 6.18 9.74 9.95 
1czz 168 7 2.56 2.56 3.62 3.81 2.03 2.33 2.58 3.21 2.06 2.83 3.15 5.68 2.03 2.33 2.58 3.21 
1d1z 104 11 5.26 5.26 7.09 7.48 5.11 5.59 6.85 10.01 5.17 5.33 7.21 8.02 5.11 5.26 6.85 7.48 
1eg3 260 13 6.17 10.8 14.45 16.05 6.67 8.44 12.43 22.77 7.47 9.46 14.72 15.02 6.17 8.44 12.43 15.02 
1go5 59 9 3.38 3.92 4.92 5.22 2.89 3.4 3.65 4.66 4.17 4.67 11.15 12.66 2.89 3.4 3.65 4.66 
1gy7 122 5 3.73 7.64 13.05 13.73 6.01 7.96 12.23 15.15 4.46 4.59 12.19 13.71 3.73 4.59 12.19 13.71 
1h1r 256 12 4.37 4.92 7.09 6.55 4.42 5.04 10.24 10.18 3.86 6.12 7.99 8.03 3.86 4.92 7.09 6.55 
1i2h 104 6 2.71 3.33 3.95 4.31 3.77 3.77 8.36 10.09 3.29 3.33 4.64 4.63 2.71 3.33 3.95 4.31 
1i7g 267 12 1.68 2.01 2.87 7.9 2.26 2.47 2.78 3.38 1.75 1.83 1.83 1.87 1.68 1.83 1.83 1.87 
1ie9 240 12 6.93 11.86 13.99 23.44 4.85 7.75 10.22 12.85 6.88 10.98 12.36 15.34 4.85 7.75 10.22 12.85 
1jbe 128 13 4.84 5.44 5.75 6.08 4.52 5.76 5.92 6.44 4.37 4.58 7.97 10.79 4.37 4.58 5.75 6.08 
1jwf 140 5 2.17 3.89 4.46 4.7 2.52 2.52 4.94 5.71 2.35 2.46 4.24 5.96 2.17 2.46 4.24 4.7 
1jwt 250 6 9.44 14.28 17.25 17.23 8.68 11.8 14.42 15.36 9.8 14.08 17.4 19.47 8.68 11.8 14.42 15.36 
1lf7 173 11 5.68 7.47 7.6 7.74 4.1 4.97 4.98 4.83 4.89 5.53 6.87 7.59 4.1 4.97 4.98 4.83 
1lvb 229 7 5.73 7.41 13.21 18.56 5.73 13.74 14.39 18.3 7.12 7.12 15.6 17.56 5.73 7.12 13.21 17.56 
1m7d 435 8 5.61 6.35 7.4 13.37 5.29 5.84 6.78 13.62 3.94 4.67 5.5 5.89 3.94 4.67 5.5 5.89 
1n7e 86 8 4.79 4.79 8.03 11.97 4.08 8.01 11.44 11.26 3.79 6.19 10.49 16.36 3.79 4.79 8.03 11.26 
1n83 244 10 1.12 1.13 1.13 2.39 2.73 2.73 3.74 3.84 1.48 3.56 8.3 8.56 1.12 1.13 1.13 2.39 
1oew 330 8 7.92 8.65 9.87 10.63 5.72 8.05 8.09 9.18 6.58 6.58 7.84 9 5.72 6.58 7.84 9 
1oot 60 11 3.43 4.62 5.97 6.97 4.27 4.97 6.1 6.9 3.97 4.62 5.73 7.12 3.43 4.62 5.73 6.9 
1ou9 106 8 3.58 4.21 4.97 6.78 3.64 3.64 4.93 11.23 3.25 4.56 4.81 5.18 3.25 3.64 4.81 5.18 
1pyw 369 15 3.62 3.65 3.79 4.68 4.62 5.23 5.54 5.8 3.93 5.5 5.55 6.33 3.62 3.65 3.79 4.68 
1qbh 105 8 4.72 7.01 9.44 13.51 5.44 6 8.96 12.8 6.09 6.09 8.51 10.44 4.72 6 8.51 10.44 
1r6j 164 5 2.52 2.52 8.26 9.3 3.21 3.23 5.43 8.31 3.2 3.72 4.94 8.47 2.52 2.52 4.94 8.31 
1rwz 245 11 6.17 10.34 11.2 23.02 4.71 4.71 8.11 19.96 4.73 4.89 6.67 7.61 4.71 4.71 6.67 7.61 
1tq3 115 6 1.4 1.4 3.57 6.44 3.58 5.63 7.34 7.39 2.62 2.62 4.7 9.68 1.4 1.4 3.57 6.44 
1um5 431 8 3.05 3.05 3.34 3.93 3.54 3.54 5.67 4.78 4.32 4.32 5.89 7.93 3.05 3.05 3.34 3.93 
1utn 223 14 7.74 8.46 8.73 12.33 6.95 7.66 8.69 10.88 7.27 7.91 9.31 10.01 6.95 7.66 8.69 10.01 
pdb  receptor  peptide run 1 run 2 run 3  best from 3 runs 
code length (AA) length (AA) all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 
1v49 121 10 2.69 2.69 2.91 4.02 2.19 2.56 2.73 3.45 2.89 2.89 4.23 5.5 2.19 2.56 2.73 3.45 
1x2j 290 9 3.92 5.08 5.42 6 3.44 3.68 5.17 5.89 3.57 4.92 5.81 6.54 3.44 3.68 5.17 5.89 
1y0m 55 10 3.92 4.97 5.73 7.03 3.53 4.83 5.45 6.21 4 5.24 5.84 8.13 3.53 4.83 5.45 6.21 
1yej 442 7 4.67 5.2 10.97 19.17 5.31 6.37 8.26 12.12 4.05 5.94 8.05 7.67 4.05 5.2 8.05 7.67 
1z1m 88 9 2.76 3.46 3.72 4.68 3.31 3.48 5.26 4.54 3.39 3.52 3.75 3.62 2.76 3.46 3.72 3.62 
1z9l 238 9 4.24 5.32 6.68 8.65 4.18 4.87 5.84 6.91 3.8 4.84 4.91 5.08 3.8 4.84 4.91 5.08 
2aa2 253 12 1.84 2 2.95 3.12 2.32 2.52 2.54 2.95 1.73 2.39 2.85 4.12 1.73 2 2.54 2.95 
2abx 74 13 6.14 7.58 10.07 10.19 6.5 7.22 7.96 8.76 8.02 9.53 10.21 11.18 6.14 7.22 7.96 8.76 
2alf 164 6 1.74 2.42 2.7 4.1 2.17 2.29 3.38 3.46 1.8 1.81 2.75 2.55 1.74 1.81 2.7 2.55 
2am9 250 10 1.52 1.58 1.69 2.14 1.57 1.93 2.6 2.22 1.21 1.76 2.36 2.66 1.21 1.58 1.69 2.14 
2b9f 337 12 2.44 2.66 3.52 3.86 3.85 3.85 6.1 12.32 2.33 3.62 4.09 4.16 2.33 2.66 3.52 3.86 
2bz6 239 15 8.03 16.66 18.28 22.88 7.76 16.35 21.5 23.07 6 9.88 10.72 10.51 6 9.88 10.72 10.51 
2ds7 41 6 5.64 5.64 11.31 11.24 5.44 7.26 10.81 11.85 3.63 7.09 10.38 12.17 3.63 5.64 10.38 11.24 
2dvj 57 9 2.82 3.29 5.09 7.7 2.96 3.3 5.85 6.15 3.35 5.1 6.38 7.2 2.82 3.29 5.09 6.15 
2e45 33 10 4.43 5.35 7.11 17.03 3.38 5.57 7.04 14.19 4.07 7.35 7.97 10.34 3.38 5.35 7.04 10.34 
2f1w 137 7 2.82 7.32 7.68 7.82 3.36 4.93 5.65 6.91 3.32 3.35 3.35 7.82 2.82 3.35 3.35 6.91 
2fgq 332 8 7.95 14.74 15.97 17.58 10.19 13.38 16.67 17.32 7.73 13.64 14.87 14.82 7.73 13.38 14.87 14.82 
2g6f 64 8 3.44 3.44 6.45 6.64 3.25 4.5 5.08 4.94 3.26 5.11 6.14 7.71 3.25 3.44 5.08 4.94 
2h14 304 5 2.55 2.94 3.4 4.26 2.57 3.09 3.09 4.7 2.28 2.28 3.73 4.42 2.28 2.28 3.09 4.26 
2h3l 95 9 4.36 4.66 6.77 12.2 4.96 4.96 14.76 14.9 3.54 4.71 4.71 9.11 3.54 4.66 4.71 9.11 
2hpj 100 5 1.64 3.33 3.83 6.03 2.1 2.17 3.37 4.58 2.35 3.18 3.77 4.91 1.64 2.17 3.37 4.58 
2hwq 258 10 2.25 2.82 3.31 2.78 1.16 1.6 2.29 2.68 1.17 1.17 1.36 1.49 1.16 1.17 1.36 1.49 
2i3i 95 6 3.85 6.18 7.06 15.82 4.03 4.03 6.82 17.23 3.36 8.39 9.27 9.4 3.36 4.03 6.82 9.4 
2iog 238 9 9.98 10.51 14.36 23.02 8.77 10.68 13.32 21.29 9.46 10.35 15.22 20.05 8.77 10.35 13.32 20.05 
2j2i 266 8 3.06 4.03 10.45 11.4 3.75 6.46 8.73 11.68 3.92 6.3 9.38 11.1 3.06 4.03 8.73 11.1 
2j6k 57 8 3.27 3.8 4.07 7.3 2.98 3.39 3.39 5.62 2.77 3.06 3.34 4.03 2.77 3.06 3.34 4.03 
2o9s 67 10 3.24 3.86 5.01 6.96 3.23 4.87 5.68 6.36 3.92 4.36 5.48 6.85 3.23 3.86 5.01 6.36 
2qbh 95 6 5.11 5.99 9.29 10.33 5.21 6.29 14.34 14.67 5.03 5.03 7.98 12.62 5.03 5.03 7.98 10.33 
2qhn 264 5 4.9 6.27 7.28 9.16 3.74 3.87 7.1 5.22 4.62 5.12 8.55 9.79 3.74 3.87 7.1 5.22 
2rtm 120 6 4.44 5.13 6.41 6.93 5.28 5.57 5.96 6.79 5.09 5.25 6.2 6.49 4.44 5.13 5.96 6.49 
2yql 60 10 4.57 4.99 6.49 7.59 3.29 3.29 7.69 9.57 6.5 7.18 8.39 13.12 3.29 3.29 6.49 7.59 
3d1g 366 6 2.73 2.73 7.04 9 7.61 14.02 14.54 15.3 3.79 6.23 11.18 6.88 2.73 2.73 7.04 6.88 
3ekk 297 14 8.03 9.61 10.36 11.6 6.91 7.01 7.11 8.56 4.41 6.57 10.22 9.96 4.41 6.57 7.11 8.56 
3hau 198 7 8.66 10.03 10.04 11.73 6.24 6.24 6.8 7 8.11 8.34 8.36 9.08 6.24 6.24 6.8 7 
3nsq 211 10 3.19 4.38 6.44 10.29 2.82 3.91 4.37 8.73 2.4 2.64 3.76 5.76 2.4 2.64 3.76 5.76 
pdb  receptor  peptide run 1 run 2 run 3  best from 3 runs 
code length (AA) length (AA) all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 all top 1k top 100 top 10 
3pom 337 10 3.59 3.59 3.59 6.69 3.99 4.61 5.26 8.79 2.17 2.17 3.89 6.42 2.17 2.17 3.59 6.42 
3rdh 224 14 3.79 4.13 6.16 6.95 3.58 3.93 4.24 6.28 3.88 3.91 4.88 4.96 3.58 3.91 4.24 4.96 
3siq 97 7 5.08 5.08 9.61 10.19 7.67 7.67 8.73 15.02 8.65 8.65 8.65 14.31 5.08 5.08 8.65 10.19 
3tx7 240 14 4.01 5.77 11.11 12.75 4.14 5.07 5.28 8.25 3.22 3.69 8.73 12.59 3.22 3.69 5.28 8.25 
MEAN 191.71 9.07 4.25 5.52 7.33 9.53 4.37 5.58 7.40 9.59 4.24 5.34 7.21 8.63 3.68 4.49 6.14 7.32 
 
 
 Table S3. PDB codes of receptor pairs (in 
bound and unbound form). 
bound form 
pdb code 
unbound form 
pdb code 
1awr 2alf 
1ce1 1um5 
1cka 2dvj 
1czy 1czz 
1d4t 1d1z 
1ddv 1i2h 
1eg4 1eg3 
1er8 1oew 
1gyb 1gy7 
1hc9 2abx 
1jbu 2bz6 
1jd5 1qbh 
1jwg 1jwf 
1kl3 2rtm 
1klu 1pyw 
1lvm 1lvb 
1mfg 2h3l 
1n7f 1n7e 
1nq7 1n83 
1nvr 2qhn 
1nx1 1alv 
1oai 1go5 
1ou8 1ou9 
1pz5 1m7d 
1rxz 1rwz 
1se0 3siq 
1sfi 1utn 
1ssh 1oot 
1t4f 1z1m 
1t7r 2am9 
1tp5 1tq3 
1tw6 2i3i 
1vzq 1jwt 
1w9e 1r6j 
1x2r 1x2j 
1yuc 3tx7 
1ywo 1y0m 
1z9o 1z9l 
2a3i 2aa2 
2ak5 2g6f 
2b1z 2iog 
2b9h 2b9f 
2c3i 2j2i 
2cch 1h1r 
2ds8 2ds7 
2fgr 2fgq 
2fmf 1jbe 
2fnt 3hau 
2foj 2f1w 
2fvj 2hwq 
2h9m 2h14 
2ho2 2e45 
2hpl 2hpj 
2ipu 1yej 
2j6f 2j6k 
2o02 3rdh 
2o4j 1ie9 
2o9v 2o9s 
2p1t 3nsq 
2p54 1i7g 
2puy 2yql 
2qos 1lf7 
2r7g 3pom 
2vj0 1b9k 
2zjd 1v49 
3bu3 3ekk 
3d1e 3d1g 
3d9t 2qbh 
 
 
